With the world fighting the SARS-CoV-2 pandemic and dealing with rapidly growing numbers of COVID-19 patients worldwide, clinicians, scientists, governments and the public all want to know more about characterising patients with COVID-19, and if certain treatments are safe and effective. To this end, on 26-29 March, the Observational Health Data Sciences and Informatics (OHDSI) … Read more
The Observational Health Data Sciences and Informatics (OHDSI) international community will host a COVID-19 virtual study-a-thon this week (March 26-29) to inform healthcare decision-making in response to the current global pandemic. More than 290 people from 29 different countries have registered for the four-day online event, which will be led by researchers from Oxford University, … Read more
After the cancellation of the EU OHDSI symposium, scheduled at the end of this month, the community is bouncing back with an alternative activity: A virtual COVID-19 study-a-thon on the dates originally planned for the symposium: March 26th to 29th. If you are new to the study-a-thon concept, you can find an overview of our … Read more
We regret to inform you that the 2020 European OHDSI Symposium “Form data to impact: the journey towards improving clinical practice” is cancelled due to the COVID-19 outbreak. Read the announcement here or visit www.ohdsi-europe.org for more information.
We are excited and proud of EHDEN’s progress in year one, and on behalf of the Consortium, thank everyone who has collaborated with us on our journey so far – it has been remarkable. When we started EHDEN we were intent on ensuring we met our goals and deliverables as per plan, and importantly set … Read more
According to a recent OHDSI paper, chlorthalidone, the guideline-recommended diuretic for lowering blood pressure, causes more serious side effects than hydrochlorothiazide, a similarly effective diuretic. The findings, published in JAMA Internal Medicine, contrast with current treatment guidelines recommending chlorthalidone over hydrochlorothiazide. The results were generated by the Large-Scale Evidence Generation and Evaluation in a Network … Read more
The ambitions of the EHDEN project are high. We aim to standardise more than 100 million patient records across Europe from different geographic areas and different data sources over the coming five years. Mapping of healthcare data to the OMOP-CDM will facilitate the re-use for a variety of purposes, enhancing and accelerating research and healthcare decision-making for … Read more
Europe’s lead regulatory authority is very active in working with real work data (RWD) in its pursuit of its statutory goals of: Facilitate development and access to medicines Evaluate applications for marketing authorisation Monitor the safety of medicines across the life cycle Provide reliable information to patients and the public EMA is working towards and … Read more
Between January 13 and 17, approximately 40 people of all disciplines, from clinical to academic to Data Partners (all with data mapped to the OMOP common data model) gathered in Barcelona for the second EHDEN study-a-thon. This time, research questions were situated in the domain of Rheumatoid Arthritis as we set out to evaluate the … Read more
At the end of 2019, EHDEN launched the EHDEN ‘Directory of Service Providers’. EHDEN’s main objective is to create an EU-wide eco-system for federated analyses of real world data standardised to the OMOP CDM. By listing all EHDEN certified SMEs in this directory, we enable data partners to easily find the SME of their choice … Read more